Ethnopharmacological relevanceThe genus Garcinia has been traditionally used in tropical regions of Southeast Asia, and Africa for the treatment of fever, inflammation, gastrointestinal disorders, and wound healing. Various parts of the plant, including the bark, leaves, fruits, and stem bark, have been widely employed in traditional medicine. Garcinia species are rich in prenylated xanthones and benzophenones, which exhibit diverse pharmacological activities, particularly anti-inflammatory effects. However, despite their extensive ethnomedicinal use and increasing phytochemical investigations, pharmacological studies have primarily focused on a limited number of species, such as Garcinia mangostana and Garcinia cowa, whereas the anti-inflammatory potential of lesser-studied species, including Garcinia dryobalanoides and its major xanthone constituent, rubraxanthone, in ameliorating endothelial dysfunction remains relatively underexplored.Aim of the studyThis study evaluated the anti-inflammatory effects of rubraxanthone on LPS-induced endothelial activation.Materials and methods Rubraxanthone was isolated and characterised using NMR, HPLC, and LC–MS. Cell viability in human umbilical vein endothelial cells (HUVECs) was assessed via CCK-8 assay. HUVECs were pre-treated with rubraxanthone (2.5–10 µM) or BAY 11-7082 (10 µM) before LPS stimulation (10 µg/mL, 4 h). Expression of adhesion molecules (E-selectin, VCAM-1, ICAM-1) and cytokines (IL-6, IL-8) was evaluated using western blotting and ELISA. Leukocyte-endothelial adhesion was measured spectrophotometrically. Molecular docking assessed rubraxanthone interactions with canonical IKKβ and the IκB–NF-κB complex.ResultsRubraxanthone was isolated with 99.2% purity; its IC50 was 12.0 μM. Rubraxanthone significantly and dose-dependently reduced LPS-induced expression of adhesion molecules, IL-6, IL-8, and U937 adhesion. Insilico docking showed favourable binding affinities to IKKβ (–8.9 kcal/mol) and the IκB–NF-κB complex (–7.4 kcal/mol), supporting its inhibitory potential on NF-κB signalling.ConclusionCollectively, rubraxanthone attenuates the endothelial inflammatory response, potentially via canonical NF-κB inhibition, serving as a promising candidate for further investigation in inflammatory vascular disorders, including sepsis.